Haznar Garbacz D - Search Results

1

Development and Evaluation of Lactose-Free Single-Unit and Multiple-Unit Preparations of a BCS Class II Drug, Rivaroxaban.

Zakowiecki D, Edinger P, Papaioannou M, Wagner M, Hess T, Paszkowska J, Staniszewska M, Myslitska D, Smolenski M, Dobosz J, Garbacz G, Haznar Garbacz D. Zakowiecki D, et al. Among authors: haznar garbacz d. Pharmaceutics. 2024 Nov 20;16(11):1485. doi: 10.3390/pharmaceutics16111485. Pharmaceutics. 2024. PMID: 39598607 Free PMC article.

2

Investigating the Impact of Co-processed Excipients on the Formulation of Bromhexine Hydrochloride Orally Disintegrating Tablets (ODTs).

Woyna-Orlewicz K, Brniak W, Tatara W, Strzebońska M, Haznar-Garbacz D, Szafraniec-Szczęsny J, Antosik-Rogóż A, Wojteczko K, Strózik M, Kurek M, Jachowicz R, Mendyk A. Woyna-Orlewicz K, et al. Among authors: haznar garbacz d. Pharm Res. 2023 Dec;40(12):2947-2962. doi: 10.1007/s11095-023-03605-x. Epub 2023 Sep 19. Pharm Res. 2023. PMID: 37726407 Free PMC article.

3

Nanoemulsion Loaded with Clotrimazole Based on Rapeseed Oil for Potential Vaginal Application-Development, Initial Assessment, and Pilot Release Studies.

Smoleński M, Muschert S, Haznar-Garbacz D, Małolepsza-Jarmołowska K. Smoleński M, et al. Among authors: haznar garbacz d. Pharmaceutics. 2023 May 8;15(5):1437. doi: 10.3390/pharmaceutics15051437. Pharmaceutics. 2023. PMID: 37242679 Free PMC article.

4

Dissolution of a Biopharmaceutics Classification System Class II Free Acid from Immediate Release Tablets Containing a Microenvironmental pH Modulator: Comparison of a Biorelevant Bicarbonate Buffering System with Phosphate Buffers.

Haznar-Garbacz D, Hoc D, Garbacz G, Lachman M, Słomińska D, Romański M. Haznar-Garbacz D, et al. AAPS PharmSciTech. 2022 Jul 26;23(6):203. doi: 10.1208/s12249-022-02310-z. AAPS PharmSciTech. 2022. PMID: 35882674

5

Directly compressible formulation of immediate release rosuvastatin calcium tablets stabilized with tribasic calcium phosphate.

Zakowiecki D, Hess T, Cal K, Mikolaszek B, Garbacz G, Haznar-Garbacz D. Zakowiecki D, et al. Among authors: haznar garbacz d. Pharm Dev Technol. 2022 Apr;27(4):425-434. doi: 10.1080/10837450.2022.2073370. Epub 2022 May 8. Pharm Dev Technol. 2022. PMID: 35499305

6

Foams as unique drug delivery systems.

Hoc D, Haznar-Garbacz D. Hoc D, et al. Among authors: haznar garbacz d. Eur J Pharm Biopharm. 2021 Oct;167:73-82. doi: 10.1016/j.ejpb.2021.07.012. Epub 2021 Jul 27. Eur J Pharm Biopharm. 2021. PMID: 34325002 Free article. Review.

7

Development of a Biphasic-Release Multiple-Unit Pellet System with Diclofenac Sodium Using Novel Calcium Phosphate-Based Starter Pellets.

Zakowiecki D, Frankiewicz M, Hess T, Cal K, Gajda M, Dabrowska J, Kubiak B, Paszkowska J, Wiater M, Hoc D, Garbacz G, Haznar-Garbacz D. Zakowiecki D, et al. Among authors: haznar garbacz d. Pharmaceutics. 2021 May 28;13(6):805. doi: 10.3390/pharmaceutics13060805. Pharmaceutics. 2021. PMID: 34071381 Free PMC article.

8

The influence of physical division of tablets on the variability of release kinetics of gliclazide.

Wójcik-Pastuszka D, Biedrawa AM, Haznar-Garbacz D, Musiał WS. Wójcik-Pastuszka D, et al. Among authors: haznar garbacz d. Monatsh Chem. 2018;149(5):953-959. doi: 10.1007/s00706-018-2176-0. Epub 2018 Mar 3. Monatsh Chem. 2018. PMID: 29720769 Free PMC article.

9

Melts of Octaacetyl Sucrose as Oral-Modified Release Dosage Forms for Delivery of Poorly Soluble Compound in Stable Amorphous Form.

Haznar-Garbacz D, Kaminska E, Zakowiecki D, Lachmann M, Kaminski K, Garbacz G, Dorożyński P, Kulinowski P. Haznar-Garbacz D, et al. AAPS PharmSciTech. 2018 Feb;19(2):951-960. doi: 10.1208/s12249-017-0912-0. Epub 2017 Nov 2. AAPS PharmSciTech. 2018. PMID: 29098644

10

Multimodal approach to characterization of hydrophilic matrices manufactured by wet and dry granulation or direct compression methods.

Kulinowski P, Woyna-Orlewicz K, Obrał J, Rappen GM, Haznar-Garbacz D, Węglarz WP, Jachowicz R, Wyszogrodzka G, Klaja J, Dorożyński PP. Kulinowski P, et al. Among authors: haznar garbacz d. Int J Pharm. 2016 Feb 29;499(1-2):263-270. doi: 10.1016/j.ijpharm.2015.12.067. Epub 2016 Jan 2. Int J Pharm. 2016. PMID: 26752087

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters